Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
mi
from
Rochester, NY
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Univ. of Rochester ACTG CRS
mi
from
Rochester, NY
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
mi
from
Chapel Hill, NC
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Unc Aids Crs
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
mi
from
Durham, NC
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Duke Univ. Med. Ctr. Adult CRS
mi
from
Durham, NC
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
mi
from
Cincinnati, OH
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Univ. of Cincinnati CRS
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
mi
from
Cleveland, OH
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Case CRS
mi
from
Cleveland, OH
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
mi
from
Cleveland, OH
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
MetroHealth CRS
mi
from
Cleveland, OH
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
mi
from
Columbus, OH
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
mi
from
Pittsburgh, PA
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Pitt CRS
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
mi
from
Providence, RI
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
The Miriam Hosp. ACTG CRS
mi
from
Providence, RI
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
mi
from
Nashville, TN
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Vanderbilt Therapeutics CRS
mi
from
Nashville, TN
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
mi
from
Seattle, WA
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
University of Washington AIDS CRS
mi
from
Seattle, WA
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
mi
from
San Juan,
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Puerto Rico AIDS CRS
mi
from
San Juan,
Click here to add this to my saved trials
Improvement of Insulin Resistance After Bariatric Surgery
Mechanisms Underlying the Improvement of Insulin Resistance in Response to Bariatric Surgery
Status: Enrolling
Updated:  12/31/1969
mi
from
Boston, MA
Improvement of Insulin Resistance After Bariatric Surgery
Mechanisms Underlying the Improvement of Insulin Resistance in Response to Bariatric Surgery
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy
Prospective, Open-Label, Randomized, Controlled, Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy Using Dosage Recommending Device
Status: Enrolling
Updated:  12/31/1969
mi
from
Minneapolis, MN
Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy
Prospective, Open-Label, Randomized, Controlled, Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy Using Dosage Recommending Device
Status: Enrolling
Updated: 12/31/1969
Park Nicollet Institute / International Diabetes Center, Minneapolis, MN
mi
from
Minneapolis, MN
Click here to add this to my saved trials
The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia
The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia
Status: Enrolling
Updated:  12/31/1969
mi
from
Austin, TX
The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia
The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia
Status: Enrolling
Updated: 12/31/1969
University of Texas at Austin Human Performance Laboratory
mi
from
Austin, TX
Click here to add this to my saved trials
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Status: Enrolling
Updated:  12/31/1969
mi
from
Danville, PA
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Status: Enrolling
Updated: 12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Status: Enrolling
Updated:  12/31/1969
mi
from
Wilkes-Barre, PA
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Status: Enrolling
Updated: 12/31/1969
Geisinger Wyoming Valley Medical Center
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
mi
from
Birmingham, AL
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Alabama Clinical Therapeutics, Llc
mi
from
Birmingham, AL
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
mi
from
Aventura, FL
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
South Florida Medical Research
mi
from
Aventura, FL
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
mi
from
Coral Gables, FL
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Clinical Research of South Florida
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
mi
from
Hialeah, FL
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Neostart Corporation dba AGA Clinical Trials
mi
from
Hialeah, FL
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
mi
from
Jacksonville, FL
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Jacksonville Impotence Treatment Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
mi
from
Oviedo, FL
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Oviedo Medical Research, LLC
mi
from
Oviedo, FL
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
mi
from
Pompano Beach, FL
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Clinical Research Center of Florida
mi
from
Pompano Beach, FL
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
mi
from
Lexington, KY
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Central Kentucky Research Associates, Inc.
mi
from
Lexington, KY
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
mi
from
Shreveport, LA
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Regional Urology
mi
from
Shreveport, LA
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
mi
from
Garden City, NY
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Accumed Research Associates
mi
from
Garden City, NY
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
mi
from
New York, NY
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Manhattan Medical Research Practice PLLC
mi
from
New York, NY
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
mi
from
Columbus, OH
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Aventiv Research
mi
from
Columbus, OH
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
mi
from
Franklin, OH
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Prestige Clinical Research
mi
from
Franklin, OH
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
mi
from
Nashville, TN
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Clinical Research Associates
mi
from
Nashville, TN
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
mi
from
West Valley City, UT
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Granger Medical Clinic
mi
from
West Valley City, UT
Click here to add this to my saved trials
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
mi
from
Renton, WA
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Rainier Clinical Research Center Inc.
mi
from
Renton, WA
Click here to add this to my saved trials
Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
A Multicenter, Open-Label, Dose Escalating Study of the Safety, Tolerability and Pharmacology of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated:  12/31/1969
mi
from
Saint Louis, MO
Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
A Multicenter, Open-Label, Dose Escalating Study of the Safety, Tolerability and Pharmacology of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Barnes-Jewish Hospital/Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
A Multicenter, Open-Label, Dose Escalating Study of the Safety, Tolerability and Pharmacology of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated:  12/31/1969
mi
from
Durham, NC
Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
A Multicenter, Open-Label, Dose Escalating Study of the Safety, Tolerability and Pharmacology of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
A Multicenter, Open-Label, Dose Escalating Study of the Safety, Tolerability and Pharmacology of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated:  12/31/1969
mi
from
Winnipeg,
Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
A Multicenter, Open-Label, Dose Escalating Study of the Safety, Tolerability and Pharmacology of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Department of Pediatrics & Child Health, Health Sciences Centre Winnipeg, University of Manitoba
mi
from
Winnipeg,
Click here to add this to my saved trials
Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Concurrent Control Study of the Safety, Efficacy, Pharmacokinetic of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Adolescents and Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated:  12/31/1969
mi
from
Saint Louis, MO
Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Concurrent Control Study of the Safety, Efficacy, Pharmacokinetic of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Adolescents and Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Shriners Hospital For Children
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Concurrent Control Study of the Safety, Efficacy, Pharmacokinetic of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Adolescents and Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated:  12/31/1969
mi
from
Durham, NC
Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Concurrent Control Study of the Safety, Efficacy, Pharmacokinetic of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Adolescents and Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Concurrent Control Study of the Safety, Efficacy, Pharmacokinetic of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Adolescents and Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated:  12/31/1969
mi
from
Winnipeg,
Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Concurrent Control Study of the Safety, Efficacy, Pharmacokinetic of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Adolescents and Adults With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Health Sciences Centre Winnipeg, University of Manitoba
mi
from
Winnipeg,
Click here to add this to my saved trials
Real Time Myocardial Contrast Echocardiography and Dobutamine Stress Perfusion Magnetic Resonance Imaging
Quantification of Ventricular Mechanics/Myocardial Blood Flow Reserve in Adolescents and Adults Ages 12-50 With Congenital or Acquired Heart Disease Using Bicycle Stress With Real Time Myocardial Contrast Echo and Dobutamine Stress MRI
Status: Enrolling
Updated:  12/31/1969
mi
from
Omaha, NE
Real Time Myocardial Contrast Echocardiography and Dobutamine Stress Perfusion Magnetic Resonance Imaging
Quantification of Ventricular Mechanics/Myocardial Blood Flow Reserve in Adolescents and Adults Ages 12-50 With Congenital or Acquired Heart Disease Using Bicycle Stress With Real Time Myocardial Contrast Echo and Dobutamine Stress MRI
Status: Enrolling
Updated: 12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Safety and Efficacy of Asfotase Alfa in Juvenile Patients With Hypophosphatasia (HPP)
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Historical Control Study of the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Children With Hypophosphatasia (HPP)
Status: Enrolling
Updated:  12/31/1969
mi
from
Saint Louis, MO
Safety and Efficacy of Asfotase Alfa in Juvenile Patients With Hypophosphatasia (HPP)
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Historical Control Study of the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Children With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Shriners Hospital For Children
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety and Efficacy of Asfotase Alfa in Juvenile Patients With Hypophosphatasia (HPP)
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Historical Control Study of the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Children With Hypophosphatasia (HPP)
Status: Enrolling
Updated:  12/31/1969
mi
from
Winnipeg,
Safety and Efficacy of Asfotase Alfa in Juvenile Patients With Hypophosphatasia (HPP)
A Randomized, Open-Label, Multicenter, Multinational, Dose-Ranging, Historical Control Study of the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of ENB-0040 (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Children With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
The University of Manitoba Health Services Centre
mi
from
Winnipeg,
Click here to add this to my saved trials
The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction
The Incidence and Treatment of Insulin Resistance Among Men With Erectile
Status: Enrolling
Updated:  1/31/2006
mi
from
Hershey, PA
The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction
The Incidence and Treatment of Insulin Resistance Among Men With Erectile
Status: Enrolling
Updated: 1/31/2006
Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Does Testosterone Improve Function in Hypogonadal Older Men
Does Testosterone Improve Function in Hypogonadal Older Men
Status: Enrolling
Updated:  3/20/2006
mi
from
Gainesville, FL
Does Testosterone Improve Function in Hypogonadal Older Men
Does Testosterone Improve Function in Hypogonadal Older Men
Status: Enrolling
Updated: 3/20/2006
Nf/Sg Vhs
mi
from
Gainesville, FL
Click here to add this to my saved trials
The Effect of Thyroid Hormone Levels in Pregnant Women on the Intelligence Quotient (IQ) of Their Children
Are IQs Low in Offspring of Euthyroid Women With Low T4?
Status: Enrolling
Updated:  3/30/2006
mi
from
Scarborough, ME
The Effect of Thyroid Hormone Levels in Pregnant Women on the Intelligence Quotient (IQ) of Their Children
Are IQs Low in Offspring of Euthyroid Women With Low T4?
Status: Enrolling
Updated: 3/30/2006
Foundation for Blood Research
mi
from
Scarborough, ME
Click here to add this to my saved trials
Treatment Targets for Chronic Hypertension in Pregnancy
Treatment Targets for Chronic Hypertension in Pregnancy
Status: Enrolling
Updated:  4/26/2006
mi
from
New York, NY
Treatment Targets for Chronic Hypertension in Pregnancy
Treatment Targets for Chronic Hypertension in Pregnancy
Status: Enrolling
Updated: 4/26/2006
The New York PresbyterianHospital-Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Blood Sugars in Children With Idiopathic Seizures.
Prevalence of Hypoglycemia and/or Hyperinsulinism/Hyperammonemia Syndrome in Patients With Idiopathic Seizures.
Status: Enrolling
Updated:  9/6/2006
mi
from
Kansas City, MO
Blood Sugars in Children With Idiopathic Seizures.
Prevalence of Hypoglycemia and/or Hyperinsulinism/Hyperammonemia Syndrome in Patients With Idiopathic Seizures.
Status: Enrolling
Updated: 9/6/2006
Children's Mercy Hospitals and Clinics
mi
from
Kansas City, MO
Click here to add this to my saved trials
Feasibility of Radiofrequency Ablation in the Management of Papillary Thyroid Cancer Under Ultra-Sound Guidance.
Feasibility of Radio-Frequency Ablation in the Management of Papillary Thyroid Cancer Under Ultra-Sound Guidance
Status: Enrolling
Updated:  9/26/2006
mi
from
Baltimore, MD
Feasibility of Radiofrequency Ablation in the Management of Papillary Thyroid Cancer Under Ultra-Sound Guidance.
Feasibility of Radio-Frequency Ablation in the Management of Papillary Thyroid Cancer Under Ultra-Sound Guidance
Status: Enrolling
Updated: 9/26/2006
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-Treated Chronic Pain Patients: A Pilot Study.
Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-Treated Chronic Pain Patients: A Pilot Study.
Status: Enrolling
Updated:  11/8/2006
mi
from
Bronx, NY
Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-Treated Chronic Pain Patients: A Pilot Study.
Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-Treated Chronic Pain Patients: A Pilot Study.
Status: Enrolling
Updated: 11/8/2006
James J. Peters VAMC
mi
from
Bronx, NY
Click here to add this to my saved trials
Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.
Comparison Fenofibrate, Rosiglitazone, or Weight Loss to Decrease Cardiovascular Risk in Insulin Resistant Dyslipidemic Individuals.
Status: Enrolling
Updated:  12/1/2006
mi
from
Stanford, CA
Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.
Comparison Fenofibrate, Rosiglitazone, or Weight Loss to Decrease Cardiovascular Risk in Insulin Resistant Dyslipidemic Individuals.
Status: Enrolling
Updated: 12/1/2006
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials